Solara Active Pharma Sciences Limited (SOLARA.NS)
INR 509.75
(4.26%)
INR 509.75
(4.26%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -5.67 Billion INR | -2459.27% |
| 2022 | -221.7 Million INR | 61.87% |
| 2021 | -581.5 Million INR | -126.26% |
| 2020 | 2.21 Billion INR | 93.18% |
| 2019 | 1.14 Billion INR | 92.53% |
| 2018 | 595.27 Million INR | 15689.66% |
| 2017 | 3.77 Million INR | -98.75% |
| 2016 | 301.64 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -134.6 Million INR | 94.73% |
| 2024 Q2 | 80.1 Million INR | 159.51% |
| 2023 Q4 | -2.55 Billion INR | 7.26% |
| 2023 FY | -5.67 Billion INR | -2459.27% |
| 2023 Q1 | -195.5 Million INR | -619.95% |
| 2023 Q2 | -171.6 Million INR | 12.23% |
| 2023 Q3 | -2.75 Billion INR | -1504.55% |
| 2022 Q2 | -99.6 Million INR | 39.38% |
| 2022 Q4 | 37.6 Million INR | 735.56% |
| 2022 FY | -221.7 Million INR | 61.87% |
| 2022 Q1 | -164.3 Million INR | -973.94% |
| 2022 Q3 | 4.5 Million INR | 104.52% |
| 2021 Q2 | 297.1 Million INR | -40.73% |
| 2021 FY | -581.5 Million INR | -126.26% |
| 2021 Q1 | 501.3 Million INR | -11.51% |
| 2021 Q4 | 18.8 Million INR | 101.34% |
| 2021 Q3 | -1.39 Billion INR | -570.78% |
| 2020 Q1 | 422.8 Million INR | 137.26% |
| 2020 Q4 | 566.5 Million INR | -13.91% |
| 2020 FY | 2.21 Billion INR | 93.18% |
| 2020 Q2 | 566.7 Million INR | 34.04% |
| 2020 Q3 | 658 Million INR | 16.11% |
| 2019 Q4 | 178.2 Million INR | -56.91% |
| 2019 Q3 | 413.6 Million INR | 43.06% |
| 2019 Q2 | 289.1 Million INR | 9.01% |
| 2019 FY | 1.14 Billion INR | 92.53% |
| 2019 Q1 | 265.2 Million INR | 0.73% |
| 2018 FY | 595.27 Million INR | 15689.66% |
| 2018 Q4 | 263.27 Million INR | 19.18% |
| 2018 Q3 | 220.9 Million INR | 158.97% |
| 2018 Q2 | 85.3 Million INR | 233.2% |
| 2018 Q1 | 25.6 Million INR | -59.37% |
| 2017 Q2 | 202.04 Million INR | 27.66% |
| 2017 Q1 | 158.26 Million INR | 0.0% |
| 2017 FY | 3.77 Million INR | -98.75% |
| 2017 Q4 | 63 Million INR | 0.0% |
| 2016 FY | 301.64 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 192.136% |
| Hester Biosciences Limited | 188.89 Million INR | 3103.812% |
| Aarti Drugs Limited | 1.71 Billion INR | 430.998% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | 361.588% |
| Albert David Limited | 754.2 Million INR | 852.306% |
| Alembic Limited | 2.68 Billion INR | 311.225% |
| Alkem Laboratories Limited | 17.95 Billion INR | 131.596% |
| Bafna Pharmaceuticals Limited | 73.47 Million INR | 7821.798% |
| Bajaj HealthCare Limited | -837.93 Million INR | -577.132% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | 80104.23% |
| Brooks Laboratories Limited | -195.91 Million INR | -2796.044% |
| Eris Lifesciences Limited | 3.91 Billion INR | 244.749% |
| FDC Limited | 3.05 Billion INR | 285.893% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 220.494% |
| Gufic Biosciences Limited | 861.35 Million INR | 758.717% |
| Hikal Limited | 696 Million INR | 915.216% |
| Ind-Swift Limited | 142.31 Million INR | 4086.916% |
| Innova Captab Limited | 943.45 Million INR | 701.399% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | 522.071% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | 2625.887% |
| Jubilant Pharmova Limited | 771 Million INR | 835.914% |
| Lincoln Pharmaceuticals Limited | 933.04 Million INR | 708.103% |
| Lupin Limited | 19.14 Billion INR | 129.637% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | -6154.506% |
| Medico Remedies Limited | 82.9 Million INR | 6943.527% |
| Morepen Laboratories Limited | 961.59 Million INR | 690.048% |
| Nectar Lifesciences Limited | 49.95 Million INR | 11459.159% |
| Orchid Pharma Limited | 921.66 Million INR | 715.614% |
| Procter & Gamble Health Limited | 2 Billion INR | 382.312% |
| RPG Life Sciences Limited | 876.6 Million INR | 747.262% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | 3985.86% |
| Sigachi Industries Limited | 571.8 Million INR | 1092.284% |
| Suven Pharmaceuticals Limited | 3 Billion INR | 288.953% |
| Themis Medicare Limited | 435.23 Million INR | 1403.632% |
| Unichem Laboratories Limited | -704.74 Million INR | -705.102% |
| Vaishali Pharma Limited | 7.18 Million INR | 79024.746% |
| Wanbury Limited | 559.56 Million INR | 1113.988% |
| Windlas Biotech Limited | 581.87 Million INR | 1075.115% |
| ZIM Laboratories Limited | 172.46 Million INR | 3389.904% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | 234.784% |
| Ipca Laboratories Limited | 5.47 Billion INR | 203.661% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 105.925% |
| Venus Remedies Limited | 284.9 Million INR | 2091.485% |
| Sakar Healthcare Limited | 116.7 Million INR | 4961.579% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 117.882% |
| Divi's Laboratories Limited | 16 Billion INR | 135.462% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | 451.303% |
| Mankind Pharma Limited | 19.12 Billion INR | 129.661% |
| Sequent Scientific Limited | -358.69 Million INR | -1481.839% |
| Laurus Labs Limited | 1.6 Billion INR | 453.404% |
| Neuland Laboratories Limited | 3 Billion INR | 289.08% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 202.671% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 62.216% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 114.701% |
| Amrutanjan Health Care Limited | 449.72 Million INR | 1361.635% |
| Wockhardt Limited | -4.63 Billion INR | -22.546% |
| Bal Pharma Limited | 73.92 Million INR | 7775.523% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 110.189% |
| Bliss GVS Pharma Limited | 754.54 Million INR | 851.967% |
| Par Drugs and Chemicals Limited | 145.01 Million INR | 4012.765% |
| Caplin Point Laboratories Limited | 4.57 Billion INR | 224.131% |
| Shilpa Medicare Limited | 318.74 Million INR | 1880.092% |
| Valiant Laboratories Limited | 3.19 Million INR | 177631.289% |
| Ajanta Pharma Limited | 8.16 Billion INR | 169.519% |
| Aarey Drugs & Pharmaceuticals Limited | 46.83 Million INR | 12214.226% |
| Granules India Limited | 4.05 Billion INR | 239.989% |
| Medicamen Biotech Limited | 109.31 Million INR | 5290.65% |
| Syncom Formulations (India) Limited | 253.14 Million INR | 2341.39% |
| Piramal Enterprises Limited | -16.83 Billion INR | 66.298% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 134.255% |
| NATCO Pharma Limited | 13.88 Billion INR | 140.869% |
| Suven Life Sciences Limited | -1.05 Billion INR | -439.979% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | -2776.006% |
| Strides Pharma Science Limited | -706.14 Million INR | -703.509% |
| Indoco Remedies Limited | 984.6 Million INR | 676.264% |
| Alpa Laboratories Limited | 167.76 Million INR | 3482.052% |
| Lasa Supergenerics Limited | -217.3 Million INR | -2511.019% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | -46.531% |